We are live on ! Find out more
CNFG

Creegan & Nassoura Financial Group Portfolio holdings

AUM $154M
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+17.18%
3 Year Est. Return
+52.61%
5 Year Est. Return
+77.6%
10 Year Est. Return
AUM
$117M
AUM Growth
+$4.84M
Cap. Flow
-$1.57M
Cap. Flow %
-1.34%
Top 10 Hldgs %
30.84%
Holding
76
New
4
Increased
1
Reduced
54
Closed
2

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$800K
2
FRT icon
Federal Realty Investment Trust
FRT
+$264K
3
KMI icon
Kinder Morgan
KMI
+$241K
4
AAPL icon
Apple
AAPL
+$207K
5
ETN icon
Eaton
ETN
+$135K

Sector Composition

Rank Sector Weight
1 Industrials 19.67%
2 Financials 18.26%
3 Consumer Staples 12.77%
4 Healthcare 12.12%
5 Technology 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$5.25M 4.49%
19,384
-300
-2% -$76.3K
BX icon
2
Blackstone
BX
$104B
$3.97M 3.4%
40,900
-894
-2% -$79.4K
JPM icon
3
JPMorgan Chase
JPM
$916B
$3.92M 3.35%
25,178
-796
-3% -$125K
DEO icon
4
Diageo
DEO
$49.6B
$3.82M 3.27%
19,936
-699
-3% -$130K
PG icon
5
Procter & Gamble
PG
$340B
$3.79M 3.24%
28,059
-708
-2% -$95.8K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.25M 2.78%
11,691
-302
-3% -$84.4K
UNP icon
7
Union Pacific
UNP
$174B
$3.14M 2.68%
14,263
-324
-2% -$72.1K
ETN icon
8
Eaton
ETN
$141B
$3.08M 2.64%
20,802
-935
-4% -$135K
BLK icon
9
Blackrock
BLK
$167B
$3.03M 2.59%
3,460
-125
-3% -$106K
JNJ icon
10
Johnson & Johnson
JNJ
$640B
$2.83M 2.42%
17,181
-698
-4% -$116K
ITW icon
11
Illinois Tool Works
ITW
$84.1B
$2.72M 2.33%
12,178
-350
-3% -$80.1K
DE icon
12
Deere & Co
DE
$165B
$2.69M 2.3%
7,616
-200
-3% -$73K
AAPL icon
13
Apple
AAPL
$4.97T
$2.68M 2.29%
19,590
-1,600
-8% -$207K
WPC icon
14
W.P. Carey
WPC
$16.6B
$2.6M 2.22%
35,592
-408
-1% -$29.9K
PFF icon
15
iShares Preferred and Income Securities ETF
PFF
$13.1B
$2.58M 2.2%
65,550
-1,650
-2% -$63.9K
GIS icon
16
General Mills
GIS
$20.2B
$2.47M 2.11%
40,465
-890
-2% -$55K
DIS icon
17
Walt Disney
DIS
$171B
$2.4M 2.05%
13,633
-150
-1% -$27K
OEF icon
18
iShares S&P 100 ETF
OEF
$19.5B
$2.35M 2.01%
11,995
-205
-2% -$39K
ENB icon
19
Enbridge
ENB
$120B
$2.27M 1.94%
56,600
-850
-1% -$32.9K
EPD icon
20
Enterprise Products Partners
EPD
$83.7B
$2.23M 1.91%
92,403
-2,400
-3% -$56.8K
BA icon
21
Boeing
BA
$169B
$2.18M 1.86%
9,082
-300
-3% -$72.5K
FDX icon
22
FedEx
FDX
$73B
$2.12M 1.81%
7,111
-75
-1% -$22.3K
CVS icon
23
CVS Health
CVS
$135B
$2.09M 1.79%
25,027
-800
-3% -$65.5K
SCHA icon
24
Schwab U.S Small- Cap ETF
SCHA
$21.8B
$2.03M 1.74%
78,020
-2,500
-3% -$63.9K
NVS icon
25
Novartis
NVS
$302B
$1.88M 1.61%
20,650
-675
-3% -$60.1K

Similar funds

Creegan & Nassoura Financial Group's Q2 2021 Portfolio in Review

As of Q2 2021, Creegan & Nassoura Financial Group held 76 positions worth $117M, up 4.3% from $112M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Creegan & Nassoura Financial Group's Q2 2021 filing shows 4 new, 1 increased, 54 reduced and 2 closed positions. Its largest new stake was Paramount Global Class B: 37,980 shares worth $1.72M. The largest sale was Sanofi, an estimated $800K.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Staples.

  • Creegan & Nassoura Financial Group's largest Q2 2021 buy was Paramount Global Class B: 37,980 shares worth $1.72M.
  • Creegan & Nassoura Financial Group added most to Toronto Dominion Bank in Q2 2021, an estimated $299K increase.
  • Creegan & Nassoura Financial Group's biggest Q2 2021 reduction was Sanofi, cutting an estimated $800K.
  • Creegan & Nassoura Financial Group fully exited Federal Realty Investment Trust in Q2 2021, selling an estimated $264K.
  • Creegan & Nassoura Financial Group's ten largest holdings make up 31% of its $117M portfolio in Q2 2021.
  • Creegan & Nassoura Financial Group opened 4 new positions and closed 2 in Q2 2021.
  • Creegan & Nassoura Financial Group's portfolio value rose 4.3% quarter-over-quarter to $117M.

Based on Creegan & Nassoura Financial Group's 13F filing for Q2 2021, filed 16 Aug 2021.